giuseppe schepisi

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Emanuela Scarpi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

Sara Bleve

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

GIOVANNI MARTINELLI

Associated Professor

University of Bologna

ITALY

View details

Vincenza Conteduca

Associate Professor

University of Foggia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

giuseppe schepisi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Validation of a Combined Prognostic Score Using Plasma Tumor DNA and Clinical Features in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Taxanes

Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care

Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer.

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors.

Immunogenomic profiles associated with response to life-prolonging agents in prostate cancer

Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment

Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel

Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome

Collaborators (4)

Emanuela Scarpi

Sara Bleve

GIOVANNI MARTINELLI

Vincenza Conteduca

Make your next move.